Shalby logo

Shalby

SHALBY NSE
₹122.71 4.03 (3.40%)
Market Cap
₹1,325 Cr
P/E
33.71

Shalby (SHALBY) share price was ₹122.71 at the 28 Oct 2026 close; market capitalisation ₹1,325 Cr; P/E (TTM) 33.71; sector Healthcare Services. The share price fell 49.1% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 11.7% year on year to ₹331.2 Cr and net profit was ₹10 Cr, against ₹8 Cr a year earlier (compared with Jun 2025). Promoters held 74.33% of Shalby in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 40/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹122.71 −118.39 −49.10% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹1,325 Cr
P/E (TTM)
33.71
EBITDA
₹170 Cr
Return on Equity
3.45%
Debt to Equity
0.59
Book Value
₹93.11
EPS (TTM)
₹3.64
52W High
₹252.05
52W Low
₹110.61

Price-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

Apollo Hospitals
₹8,137.0055.991,16,998 Cr12.340.26%20.08%19.79%26,675 Cr2,171 Cr
Manipal Health Enterprises
₹643.2585.7784,612 Cr5.150.00%10.42%9.50%11,400 Cr906 Cr
Max Healthcare Institute
₹851.5056.8482,877 Cr7.710.24%13.42%12.70%8,879 Cr1,457 Cr
Aster DM Healthcare
₹669.45108.8558,354 Cr13.870.45%8.84%9.71%5,006 Cr363 Cr
Fortis Healthcare
₹759.5054.7257,339 Cr5.790.14%10.47%12.13%9,607 Cr1,070 Cr
Narayana Hrudayalaya
₹1,723.1043.1435,213 Cr7.760.26%17.85%11.39%9,185 Cr816 Cr
Global Health
₹1,283.0062.0134,496 Cr8.710.04%13.91%15.05%4,800 Cr552 Cr
Shalby (this company)
₹122.7133.711,325 Cr1.321.01%3.45%7.88%1,203 Cr36 Cr
Median 8 companies₹805.5056.4257,847 Cr7.730.25%11.95%11.76%9,032 Cr861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
40 Weak
Overall score
Data confidence 100/100

Category scores

Quality Poor 27
Returns, margins, earnings quality 22%
Valuation Good 56
Cheap vs sector & own history 24%
Growth Poor 27
Sales & profit trajectory 9%
Financial Health Poor 24
Solvency, leverage, coverage 9%
Momentum Poor 15
Trend strength, vol-adjusted 12%
Ownership Good 61
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company's working capital requirements have reduced from 32.0 days to 21.7 days

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 3.11% over last 3 years.
  • Dividend payout has been low at 5.11% of profits over last 3 years

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
3
Neutral
5
Bullish
1

Overall

BearishNeutralBullish

Bearish

Bearish
11
Neutral
5
Bullish
3

Moving Averages

BearishNeutralBullish

Bearish

Bearish
8
Neutral
0
Bullish
2
Analyst Rating
Based on 1 analysts
BUY SHARE100%

1 of 1 analyst rates Buy, 0 Hold, 0 Sell.

Updated 28 Oct 2026

BUY
1
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

Revenue Growth
4.81% lower than 3Y

change over 1 year

Net Income Growth
—

Cash Flow Change
99.77%

change over 1 year

EBITDA Margin Change
0.97%

change over 1 year Operating margin 13% · Jun 2026

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹153 Cr −9.8% vs FY26
Reported High Mean Low

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
235
238
216
244
279
268
276
265
296
285
272
287
331
Expenses
192
185
174
205
234
235
242
244
255
244
242
258
290
Operating Profit
43
53
42
39
45
33
34
21
42
42
30
29
42
OPM %
18%
22%
20%
16%
16%
12%
12%
8%
14%
15%
11%
10%
13%
Other Income
5
5
5
5
10
7
5
5
7
4
7
8
7
Interest
3
3
4
6
8
9
11
11
9
10
11
9
11
Depreciation
12
12
12
16
16
17
16
16
17
17
18
18
19
PBT
33
43
31
22
30
14
12
-1
23
19
9
10
20
Tax %
37%
35%
38%
26%
52%
83%
124%
1547%
66%
62%
86%
-92%
47%
Net Profit
21
28
19
16
15
2
-3
-12
8
7
1
18
10
EPS (₹)
1.93
2.55
1.77
1.54
1.45
0.31
-0.17
-1.02
0.83
0.78
0.16
1.7
1
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
275
290
324
378
462
487
431
699
805
934
1,087
1,141
1,176
Expenses
207
235
252
299
379
404
342
577
667
755
952
996
1,033
Operating Profit
68
56
71
79
83
83
89
122
138
179
135
145
143
OPM %
25%
19%
22%
21%
18%
17%
21%
17%
17%
19%
12%
13%
12%
Other Income
2
2
7
10
9
17
8
8
22
19
28
27
27
Interest
5
10
11
12
9
7
5
8
11
18
41
41
40
Depreciation
21
11
17
23
33
36
37
43
48
52
66
70
72
PBT
43
36
50
54
50
57
55
79
102
128
56
61
58
Tax %
43%
-1%
43%
27%
37%
51%
23%
32%
34%
35%
97%
43%
—
Net Profit
25
36
29
39
32
28
42
54
68
84
2
35
38
EPS (₹)
2.94
4.3
3.4
3.65
2.93
2.55
3.93
5.01
6.27
7.78
0.58
3.46
3.64
Div. Payout %
0%
0%
0%
0%
17%
20%
25%
20%
19%
15%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
35
87
87
108
108
108
108
108
107
107
107
108
Reserves
133
117
164
643
672
691
727
768
820
893
885
898
Borrowings
98
224
328
114
71
62
44
155
180
378
476
595
Other Liabilities
85
75
99
96
89
105
118
162
173
231
241
248
Total Liabilities
351
504
679
961
939
967
997
1,194
1,281
1,609
1,709
1,848
Fixed Assets
175
319
323
650
692
672
660
675
685
966
955
1,046
CWIP
91
82
221
47
3
6
8
6
11
15
22
19
Investments
0
0
0
0
11
28
16
25
146
81
95
62
Other Assets
85
102
134
264
233
260
314
488
440
547
637
721
Total Assets
351
504
679
961
939
967
997
1,194
1,281
1,609
1,709
1,848
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
—
60
14
43
55
79
19
68
20
-4
0
Investing
—
—
-153
-236
1
-31
-51
-60
-61
146
-36
-97
Financing
—
—
96
222
-51
-22
-30
90
-50
-151
48
84
Net Cash Flow
—
—
3
0
-6
3
-2
49
-43
15
8
-13
Free Cash Flow
—
—
-98
-124
12
244
58
-56
50
-26
-74
-145
CFO/EBITDA
—
—
99
34
63
91
99
34
70
22
7
27
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
29
40
38
49
64
71
80
53
48
57
59
73
Inventory Days
—
—
77
113
119
105
242
1,063
1,152
1,361
1,033
928
Days Payable
—
—
395
462
522
415
606
621
546
744
377
310
Cash Conversion Cycle
29
40
-280
-299
-339
-239
-283
495
654
673
715
692
Working Capital Days
-46
-26
-64
-18
57
70
77
75
75
48
26
22
ROCE %
22%
13%
12%
9%
7%
7%
7%
10%
10%
11%
6%
6%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Shalby insights

65 extracted metrics + investor summaries across FY08–FY27.

Shareholding Pattern

DIIs0.31%Promot.74.33%FIIs4.65%Others8.65%Public12.06%As ofSep 2026

Documents

Frequently Asked Questions about Shalby

What does Shalby Ltd do?
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replac...
Where is Shalby Ltd (SHALBY) listed?
Shalby Ltd trades as SHALBY on the NSE and under code 540797 on the BSE.
Which sector does Shalby Ltd belong to?
Shalby Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Shalby Ltd?
Shalby Ltd has a market capitalisation of ₹1,325 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Shalby Ltd?
Shalby Ltd trades at a PE ratio of 33.71 as of 28 Oct 2026, on earnings per share of ₹3.64, against a book value of ₹93.11 per share.
What is the 52-week high and low of Shalby Ltd?
Over the last 52 weeks Shalby Ltd has traded between ₹110.61 and ₹252.05 as of 28 Oct 2026.
Does Shalby Ltd pay dividends?
Shalby Ltd has a dividend yield of 1.01%.
What is the Return on Equity (ROE) of Shalby Ltd?
Shalby Ltd reported a return on equity of 3.45%. Its debt-to-equity ratio is 0.59.

Company Information

Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc.[1] The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.

Website shalby.org
CEO Dr. Vikram I. Shah
Employees 2,592
Listed 2017-12-15
Face Value ₹ 10
Shares Outstanding 10,80,09,770

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHALBY.md for Shalby Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month